OA13229A - Supplement preparation. - Google Patents

Supplement preparation. Download PDF

Info

Publication number: OA13229A
Authority: OA; OAPI
Prior art keywords: preparation; silver; active component; cartilage; preparation according
Prior art date: 2003-08-05

Application number

OA1200600039A

Other languages

English (en)

Inventor

Jorn Oddershede Thomsen

Original Assignee

Jorn Oddershede Thomsen

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-08-05

Filing date

2004-08-02

Publication date

2006-12-13

2004-08-02 Application filed by Jorn Oddershede Thomsen filed Critical Jorn Oddershede Thomsen

2006-12-13 Publication of OA13229A publication Critical patent/OA13229A/en

Links

238000002360 preparation method Methods 0.000 title claims abstract description 72
239000013589 supplement Substances 0.000 title claims abstract description 27
229910052709 silver Inorganic materials 0.000 claims abstract description 51
239000004332 silver Substances 0.000 claims abstract description 50
210000000845 cartilage Anatomy 0.000 claims abstract description 26
241000772415 Neovison vison Species 0.000 claims abstract description 20
201000010099 disease Diseases 0.000 claims abstract description 11
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 11
244000144972 livestock Species 0.000 claims abstract description 11
239000000654 additive Substances 0.000 claims abstract description 7
239000003795 chemical substances by application Substances 0.000 claims abstract description 7
241000700605 Viruses Species 0.000 claims abstract description 5
206010035485 plasmacytosis Diseases 0.000 claims abstract description 5
208000004232 Enteritis Diseases 0.000 claims abstract description 3
208000006536 Ephemeral Fever Diseases 0.000 claims abstract description 3
230000002265 prevention Effects 0.000 claims abstract description 3
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 56
241000251730 Chondrichthyes Species 0.000 claims description 14
239000000126 substance Substances 0.000 claims description 13
ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 10
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 9
239000000843 powder Substances 0.000 claims description 9
229910052725 zinc Inorganic materials 0.000 claims description 7
239000011701 zinc Substances 0.000 claims description 7
229910052787 antimony Inorganic materials 0.000 claims description 6
WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 claims description 6
150000003751 zinc Chemical class 0.000 claims description 6
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 5
229910021626 Tin(II) chloride Inorganic materials 0.000 claims description 5
239000011630 iodine Substances 0.000 claims description 5
229910052740 iodine Inorganic materials 0.000 claims description 5
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 4
239000005864 Sulphur Substances 0.000 claims description 4
241000251468 Actinopterygii Species 0.000 claims description 2
239000000306 component Substances 0.000 claims 13
239000000463 material Substances 0.000 abstract description 10
244000144977 poultry Species 0.000 abstract description 5
241000282887 Suidae Species 0.000 abstract 1
241001465754 Metazoa Species 0.000 description 26
239000013543 active substance Substances 0.000 description 12
239000010944 silver (metal) Substances 0.000 description 12
230000037396 body weight Effects 0.000 description 8
230000036541 health Effects 0.000 description 8
210000000987 immune system Anatomy 0.000 description 8
239000003242 anti bacterial agent Substances 0.000 description 6
229940088710 antibiotic agent Drugs 0.000 description 6
238000009395 breeding Methods 0.000 description 6
230000001488 breeding effect Effects 0.000 description 6
239000000470 constituent Substances 0.000 description 6
230000000694 effects Effects 0.000 description 6
210000004185 liver Anatomy 0.000 description 6
230000000069 prophylactic effect Effects 0.000 description 5
241001409295 Handroanthus impetiginosus Species 0.000 description 4
239000006185 dispersion Substances 0.000 description 4
230000008821 health effect Effects 0.000 description 4
235000013402 health food Nutrition 0.000 description 4
244000144980 herd Species 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
238000012360 testing method Methods 0.000 description 4
QPBYLOWPSRZOFX-UHFFFAOYSA-J tin(iv) iodide Chemical compound I[Sn](I)(I)I QPBYLOWPSRZOFX-UHFFFAOYSA-J 0.000 description 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
208000035473 Communicable disease Diseases 0.000 description 3
241000282339 Mustela Species 0.000 description 3
206010028980 Neoplasm Diseases 0.000 description 3
238000009825 accumulation Methods 0.000 description 3
201000011510 cancer Diseases 0.000 description 3
239000000084 colloidal system Substances 0.000 description 3
CHETUOSYZGKTOC-UHFFFAOYSA-L zinc;3-methylbutanoate Chemical compound [Zn+2].CC(C)CC([O-])=O.CC(C)CC([O-])=O CHETUOSYZGKTOC-UHFFFAOYSA-L 0.000 description 3
241000086254 Arnica montana Species 0.000 description 2
240000000724 Berberis vulgaris Species 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
206010012735 Diarrhoea Diseases 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
229920002683 Glycosaminoglycan Polymers 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
244000269722 Thea sinensis Species 0.000 description 2
GLXGDSIDFQEZRG-UHFFFAOYSA-N [Ca].[I] Chemical compound [Ca].[I] GLXGDSIDFQEZRG-UHFFFAOYSA-N 0.000 description 2
238000007792 addition Methods 0.000 description 2
235000019789 appetite Nutrition 0.000 description 2
230000036528 appetite Effects 0.000 description 2
230000008901 benefit Effects 0.000 description 2
229910052791 calcium Inorganic materials 0.000 description 2
239000011575 calcium Substances 0.000 description 2
230000006378 damage Effects 0.000 description 2
230000034994 death Effects 0.000 description 2
231100000517 death Toxicity 0.000 description 2
230000006872 improvement Effects 0.000 description 2
229940102223 injectable solution Drugs 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
230000008092 positive effect Effects 0.000 description 2
239000000047 product Substances 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
241000256836 Apis Species 0.000 description 1
241000256844 Apis mellifera Species 0.000 description 1
241000512259 Ascophyllum nodosum Species 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
235000016068 Berberis vulgaris Nutrition 0.000 description 1
241001474374 Blennius Species 0.000 description 1
241000712083 Canine morbillivirus Species 0.000 description 1
229920001287 Chondroitin sulfate Polymers 0.000 description 1
206010011224 Cough Diseases 0.000 description 1
208000000655 Distemper Diseases 0.000 description 1
241001669573 Galeorhinus galeus Species 0.000 description 1
241001012590 Juniperus communis subsp. communis Species 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
241001466453 Laminaria Species 0.000 description 1
241001236644 Lavinia Species 0.000 description 1
241000212321 Levisticum Species 0.000 description 1
241000212322 Levisticum officinale Species 0.000 description 1
241000198694 Passiflora pallida Species 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
241001530102 Tabebuia Species 0.000 description 1
240000000828 Tecoma stans Species 0.000 description 1
238000013019 agitation Methods 0.000 description 1
230000004075 alteration Effects 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
230000033115 angiogenesis Effects 0.000 description 1
239000002870 angiogenesis inducing agent Substances 0.000 description 1
238000003975 animal breeding Methods 0.000 description 1
230000001772 anti-angiogenic effect Effects 0.000 description 1
230000002456 anti-arthritic effect Effects 0.000 description 1
230000003356 anti-rheumatic effect Effects 0.000 description 1
239000003435 antirheumatic agent Substances 0.000 description 1
229930187284 avellanedae Natural products 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
238000009835 boiling Methods 0.000 description 1
206010006451 bronchitis Diseases 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
JGIATAMCQXIDNZ-UHFFFAOYSA-N calcium sulfide Chemical compound [Ca]=S JGIATAMCQXIDNZ-UHFFFAOYSA-N 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
230000006866 deterioration Effects 0.000 description 1
230000002542 deteriorative effect Effects 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
230000006806 disease prevention Effects 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
239000003814 drug Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
210000003608 fece Anatomy 0.000 description 1
239000010946 fine silver Substances 0.000 description 1
230000005802 health problem Effects 0.000 description 1
230000010224 hepatic metabolism Effects 0.000 description 1
230000008676 import Effects 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
239000008101 lactose Substances 0.000 description 1
239000001645 levisticum officinale Substances 0.000 description 1
239000010871 livestock manure Substances 0.000 description 1
208000004396 mastitis Diseases 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
229910021645 metal ion Inorganic materials 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000000203 mixture Substances 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
239000002245 particle Substances 0.000 description 1
244000052769 pathogen Species 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
230000002028 premature Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
238000003980 solgel method Methods 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000005728 strengthening Methods 0.000 description 1
YPMOSINXXHVZIL-UHFFFAOYSA-N sulfanylideneantimony Chemical compound [Sb]=S YPMOSINXXHVZIL-UHFFFAOYSA-N 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
-1 tin halide Chemical class 0.000 description 1
230000003313 weakening effect Effects 0.000 description 1
229940120347 zinc preparations Drugs 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
- A23K10/22—Animal feeding-stuffs from material of animal origin from fish
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Polymers & Plastics (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Inorganic Chemistry (AREA)
Zoology (AREA)
Food Science & Technology (AREA)
Animal Husbandry (AREA)
Biomedical Technology (AREA)
Marine Sciences & Fisheries (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biotechnology (AREA)
Birds (AREA)
Chemical Kinetics & Catalysis (AREA)
Virology (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Developmental Biology & Embryology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Cell Biology (AREA)
Rheumatology (AREA)
Physiology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Fodder In General (AREA)

OA1200600039A 2003-08-05 2004-08-02 Supplement preparation. OA13229A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DK200301128A DK200301128A (da)	2003-08-05	2003-08-05	Tilskudspræparat

Publications (1)

Publication Number	Publication Date
OA13229A true OA13229A (en)	2006-12-13

Family

ID=34112403

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
OA1200600039A OA13229A (en)	2003-08-05	2004-08-02	Supplement preparation.

Country Status (14)

Country	Link
US (1)	US7655260B2 (de)
EP (1)	EP1651061B1 (de)
JP (1)	JP2007501006A (de)
CN (1)	CN100444744C (de)
AP (2)	AP2006003501A0 (de)
AT (1)	ATE415825T1 (de)
AU (1)	AU2004260578B2 (de)
CA (1)	CA2532883A1 (de)
DE (1)	DE602004018149D1 (de)
DK (2)	DK200301128A (de)
EA (1)	EA011386B1 (de)
OA (1)	OA13229A (de)
UA (1)	UA85060C2 (de)
WO (1)	WO2005011400A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE202008014500U1 (de) *	2008-10-31	2009-01-22	Schreiber, Monika Christine	Futtermittel für Tiere
RU2425587C1 (ru) *	2009-12-24	2011-08-10	Сергей Иванович Першин	Кормовой продукт для продуктивных сельскохозяйственных животных и птиц

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4746504A (en) *	1986-03-14	1988-05-24	Bio-Technology General Corp.	Heavy metal salts of hyaluronic acid and their use as antimicrobial agents
FR2618677B1 (fr) *	1987-07-31	1989-12-22	Besnouin Didier	Composition pharmaceutique destinee a la prevention et au traitement des maladies bacteriennes ou virales
JPH0341774U (de) *	1989-09-04	1991-04-22
IT1243435B (it) *	1990-10-05	1994-06-10	Altergon Sa	Composizioni farmaceutiche per uso topico comprendenti acido ialuronico sale sodico e sostanze disinfettanti
JP3159772B2 (ja) *	1992-05-08	2001-04-23	松下電器産業株式会社	抗菌性ワックス
JP3422762B2 (ja) *	1992-05-08	2003-06-30	松下電器産業株式会社	悪臭抑制ペットフード
WO1994012510A1 (en)	1992-11-30	1994-06-09	Lane I William	Processing shark cartilage
RU2087148C1 (ru) *	1993-06-24	1997-08-20	Василий Васильевич Третьяков	Способ лечения острых вирусных заболеваний животных семейства псовых
IT1281877B1 (it) *	1995-05-10	1998-03-03	Fidia Advanced Biopolymers Srl	Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici
US6017901A (en) *	1995-05-10	2000-01-25	Fidia Advanced Bioplymers S.R.L.	Heavy metal salts of succinic acid hemiesters with hyaluronic acid or hyaluronic acid esters, a process for their preparation and relative pharmaceutical compositions
AUPO920597A0 (en) *	1997-09-16	1997-10-09	Micronized Foods Pty Ltd	Pharmaceutical and/or therapeutic composition or preparation comprising shark cartilage and emu oil
JP4039719B2 (ja) *	1997-10-17	2008-01-30	富士フイルム株式会社	抗腫瘍剤
EP1128824A1 (de) *	1998-11-09	2001-09-05	Ira Jay Newman	Ionischer silberkomplex
JP2000309537A (ja) *	1999-04-28	2000-11-07	Seikagaku Kogyo Co Ltd	腸疾患予防及び／または治療剤
EP1272231A1 (de) *	2000-04-06	2003-01-08	University Technology Corporation	Zusammensetzungen und verfahren zur förderung der wundheilung
JP2002145794A (ja)	2000-08-31	2002-05-22	Nippon Kayaku Co Ltd	抗関節炎もしくは抗リュウマチ製剤、食品又は飼料
EP1356811B1 (de)	2001-01-05	2007-02-21	Kyowa Hakko Kogyo Co., Ltd.	Kombination von drei Substanzen zur Vorbeugung und Behandlung von Arthritis
US6528040B1 (en) *	2001-01-18	2003-03-04	Maurine Pearson	EMU oil-based formulations for use as an analgesic, anesthetic and antipruritic
DE60210441T2 (de) *	2001-04-23	2006-11-16	Nucryst Pharmaceuticals Corp., Fort Saskatchewan	Arzneimittel oder pflaster enthaltend ein metall wie silber, gold, platin oder palladium als antimikrobiellen wirkstoff und dessen verwendung in der behandlung von hautentzündungen
JP2003073403A (ja) *	2001-08-31	2003-03-12	Takara Bio Inc	ムコ多糖及び／又はコラーゲン
KR20030018700A (ko) *	2001-08-31	2003-03-06	김인달	질석을 담체로 하여 은을 결합한 살균제 및 그 사용방법
EP1308155B1 (de)	2001-10-12	2006-06-21	Nipro Corporation	Injektionslösung enthaltend ein Kolloid aus Eisen und Haiknorpel-Chondroitinsulfat

2003
- 2003-08-05 DK DK200301128A patent/DK200301128A/da not_active Application Discontinuation
2004
- 2004-08-02 AT AT04739018T patent/ATE415825T1/de not_active IP Right Cessation
- 2004-08-02 CA CA002532883A patent/CA2532883A1/en not_active Abandoned
- 2004-08-02 AU AU2004260578A patent/AU2004260578B2/en not_active Expired - Fee Related
- 2004-08-02 DE DE602004018149T patent/DE602004018149D1/de not_active Expired - Lifetime
- 2004-08-02 AP AP2003001128A patent/AP2006003501A0/xx unknown
- 2004-08-02 US US10/566,729 patent/US7655260B2/en not_active Expired - Fee Related
- 2004-08-02 UA UAA200602386A patent/UA85060C2/ru unknown
- 2004-08-02 DK DK04739018T patent/DK1651061T3/da active
- 2004-08-02 WO PCT/DK2004/000521 patent/WO2005011400A1/en not_active Ceased
- 2004-08-02 OA OA1200600039A patent/OA13229A/en unknown
- 2004-08-02 EP EP04739018A patent/EP1651061B1/de not_active Expired - Lifetime
- 2004-08-02 EA EA200600365A patent/EA011386B1/ru not_active IP Right Cessation
- 2004-08-02 AP AP2006003501A patent/AP2031A/xx active
- 2004-08-02 CN CNB200480022356XA patent/CN100444744C/zh not_active Expired - Fee Related
- 2004-08-02 JP JP2006522234A patent/JP2007501006A/ja active Pending

Also Published As

Publication number	Publication date
AP2006003501A0 (en)	2006-02-28
AU2004260578B2 (en)	2010-07-29
JP2007501006A (ja)	2007-01-25
DK200301128A (da)	2005-02-06
WO2005011400A1 (en)	2005-02-10
AU2004260578A1 (en)	2005-02-10
AP2031A (en)	2009-08-24
US7655260B2 (en)	2010-02-02
DE602004018149D1 (de)	2009-01-15
EP1651061B1 (de)	2008-12-03
CN1842276A (zh)	2006-10-04
ATE415825T1 (de)	2008-12-15
US20060246147A1 (en)	2006-11-02
DK1651061T3 (da)	2009-03-30
EP1651061A1 (de)	2006-05-03
CN100444744C (zh)	2008-12-24
EA200600365A1 (ru)	2006-06-30
UA85060C2 (ru)	2008-12-25
EA011386B1 (ru)	2009-02-27
CA2532883A1 (en)	2005-02-10

Publication	Publication Date	Title
EP1176875B1 (de)	2005-01-19	Verwendung von kreatin als futterzusatz
Saha et al.	2016	Selenium in animal nutrition: deficiencies in soils and forages, requirements, supplementation and toxicity
CN110859247A (zh)	2020-03-06	组合物、制备方法及其在制备治疗宠物关节疾病药品、保健品及食品中的应用
JP2723846B2 (ja)	1998-03-09	飼料及び飼料添加物
Detwiler et al.	1950	The influence of thiouracil and stilbestrol on broiler quality
US7655260B2 (en)	2010-02-02	Supplement preparation
Ünal et al.	2006	Fattening performance and carcass traits in crossbred ram lambs
Khan et al.	2016	Role of camel in pastoral mode of life and future use of rCGH as a therapeutic agent in milk and meat production
US3826827A (en)	1974-07-30	Feed supplement for hoofed animals
AU2021321372B2 (en)	2025-03-13	Ectoparasiticide veterinary composition
RU2077320C1 (ru)	1997-04-20	Средство для нормализации обменных процессов в организме животных
CN102845360A (zh)	2013-01-02	一种富硒黑天鹅养殖方法
Wallis	1946	Vitamin D Defficiency in Dairy Cows
CN115245187A (zh)	2022-10-28	一种改善牛肉色泽的方法
Cole	2023	The American Veterinarian
Muwalla et al.	1995	Use of dried poultry litter in the diet of pregnant and lactating Awassi ewes
Kadhim	2022	Effect of supplementation of threonine, zinc and their combination on some production traits and intestinal morphology of broiler chickens
RU2375913C2 (ru)	2009-12-20	Способ кормления животных и птиц
Rowntree et al.	1938	CERTAIN IODINE-REDUCING SUBSTANCES OF THYMUS EXTRACT: BIOLOGICAL CONSIDERATIONS
Reeves	1875	The Orange County Stud Book: giving a history of all noted stallions bred and raised in Orange County; together with symptoms and treatment of the diseases of the horse
Van Heerden	1979	Hand-rearing of Cape Hunting dog Lycaon pictus pups
Taylor	1925	A study of depraved appetite in dairy cattle
Cole	1851	The American Veterinarian: Or, Diseases of Domestic Animals, Showing the Causes, Symptoms and Remedies, and Rules for Restoring and Preserving Health by Good Management...
White	1918	Poisoning of horses with castor seeds
Shively	1967	Selenium and sulfur nutrition of beef cattle